BGEAX
Price
$36.44
Change
+$0.01 (+0.03%)
Updated
Sep 11 closing price
Net Assets
84.28M
VGPMX
Price
$24.32
Change
+$0.05 (+0.21%)
Updated
Sep 11 closing price
Net Assets
3.94B
Interact to see
Advertisement

BGEAX vs VGPMX

BGEAX vs VGPMX Comparison Chart in %
View a ticker or compare two or three
VS
BGEAX vs. VGPMX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGEAX is a Buy and VGPMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGPMX has more cash in the bank: 3.94B vs. BGEAX (84.3M). VGPMX pays higher dividends than BGEAX: VGPMX (3.19) vs BGEAX (1.26). BGEAX was incepted earlier than VGPMX: BGEAX (16 years) vs VGPMX (42 years). BGEAX (1.35) is less costly to investors than VGPMX (0.42). VGPMX is a more actively managed with annual turnover of: 50.00 vs. BGEAX (31.32). BGEAX has a lower initial minimum investment than VGPMX: BGEAX (2500) vs VGPMX (3000). VGPMX annual gain was more profitable for investors over the last year : 38.91 vs. BGEAX (5.10). VGPMX return over 5 years is better than : 128.35 vs. BGEAX (49.25).
BGEAXVGPMXBGEAX / VGPMX
Total Expense Ratio1.200.42286%
Annual Report Gross Expense Ratio1.350.42321%
Fund Existence16 years42 years-
Gain YTD8.48019.31044%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets84.3M3.94B2%
Annual Yield % from dividends1.263.1939%
Returns for 1 year5.1038.9113%
Returns for 3 years44.40104.6442%
Returns for 5 years49.25128.3538%
Returns for 10 years106.47129.4882%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRL278.265.26
+1.93%
Charles River Laboratories International
TATT38.460.61
+1.61%
TAT Technologies Ltd
WAFD33.88-0.22
-0.65%
WaFd
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals
UK1.96-0.06
-2.97%
Ucommune International Ltd.